U.S.A., Europe and Japan who would benefit from treatment with tPA to be 2.8 X 106 (about 0.58% of the human population). The price of the FDA licensed tPA is currently $2,200 per dose or $22,000 g"1.
At this stage it is worthwhile comparing actual sales of recombinant products with those of some other fermentation products. Since their introduction in the 1980s, the total sales of four new secondary metabolites, cyclosporin (an immunoregulator), imipen (a broad spectrum antibiotic), lovastatin (controller of cholesterol levels) and ivermectin (antiparasitic compound), have been higher than those of all the recombinant products (Buckland, 1992).
The life expectancy of a compound will have to be predicted even when covered by a patent. This is sometimes difficult, as has been demonstrated with the industrial enzyme market (Aunstrup, 1977). In about 1965 detergent enzymes became widely used, which led to a general increase in sales of microbial enzymes. In 1971 allergic symptoms were discovered in workers handling enzymes in a detergent factory, resulting in the removal of enzymes from most detergent powders and a sudden drop in enzyme sales. Enzyme sales recovered after the introduction of improved process techniques.
Was this article helpful?
You may be forgiven for thinking that these passed down secrets had gone for good, washed away with time and the modern age, But they're not. You can now own three of the best traditional did you know style reports that were much loved by our parents and grandparents. And they were pretty smart too because not only will these reports save you time and money but they'll also help you eliminate some of the scourges of modern day living such as harmful chemical usage in the home.